Biggest News Aggregation in the World
📰 Nasdaq Trml News

Nasdaq Trml News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Trml. Real-time updates on events, politics, business and more.

Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Rating of "Buy" by Analysts

Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has earned an average recommendation of “Buy” from the six brokerages that are presently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have updated their coverage on the stock in the last […]
Mark Mcdade Jefferies Financial Group Capital Management Denali Advisors Affinity Asset Advisors Tourmaline Bio Inc
Source: wkrb13.com

Tourmaline Bio (NASDAQ:TRML) Shares Down 7.8%

Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) traded down 7.8% during trading on Tuesday . The stock traded as low as $38.61 and last traded at $39.33. 64,967 shares were traded during mid-day trading, a decline of 73% from the average session volume of 238,561 shares. The stock had previously closed at […]
Leerink Partnrs Mark Mcdade Piper Sandler Tourmaline Bio Inc Tourmaline Bio Company Profile Goldman Sachs Group Inc

Tourmaline Bio (NASDAQ:TRML) Stock Price Up 3.5%

Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report)’s stock price rose 3.5% during mid-day trading on Tuesday . The stock traded as high as $38.29 and last traded at $37.80. Approximately 11,465 shares traded hands during trading, a decline of 95% from the average daily volume of 211,499 shares. The stock had previously closed at […]
Sandeep Chidambar Kulkarni Piper Sandler Jefferies Financial Group Tourmaline Bio Company Profile Tourmaline Bio Inc Tourmaline Bio

Tourmaline Bio (NASDAQ:TRML) Shares Gap Up to $36.01

Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report)’s share price gapped up prior to trading on Thursday . The stock had previously closed at $36.01, but opened at $37.60. Tourmaline Bio shares last traded at $37.47, with a volume of 329,462 shares traded. Wall Street Analysts Forecast Growth TRML has been the subject of a […]
Piper Sandler Leerink Partnrs Caley Castelein Sandeep Chidambar Kulkarni Tourmaline Bio Company Profile Jefferies Financial Group

Tourmaline Bio (NASDAQ:TRML) Reaches New 52-Week High at $35.37

Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $35.37 and last traded at $35.30, with a volume of 16661 shares changing hands. The stock had previously closed at $34.57. Wall Street Analysts Forecast Growth A number of brokerages […]
Caley Castelein Piper Sandler Sandeep Chidambar Kulkarni Leerink Partnrs Tourmaline Bio Inc Tourmaline Bio Company Profile

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Tourmaline Bio (NASDAQ:TRML) Given "Outperform" Rating at Leerink Partnrs

Leerink Partnrs reiterated their outperform rating on shares of Tourmaline Bio (NASDAQ:TRML – Free Report) in a research report released on Thursday, PriceTargets.com reports. Leerink Partnrs also issued estimates for Tourmaline Bio’s FY2026 earnings at ($4.00) EPS. A number of other research firms also recently weighed in on TRML. HC Wainwright reaffirmed a buy rating […]
New York United States Piper Sandler Caley Castelein Sandeep Chidambar Kulkarni Leerink Partnrs

Analysts Issue Forecasts for Tourmaline Bio, Inc.'s FY2026 Earnings (NASDAQ:TRML)

Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Analysts at Leerink Partnrs issued their FY2026 earnings per share (EPS) estimates for Tourmaline Bio in a research note issued to investors on Thursday, December 7th. Leerink Partnrs analyst T. Smith expects that the company will post earnings of ($4.00) per share for the year. Leerink Partnrs […]
New York United States Piper Sandler Leerink Partnrs Caley Castelein Sandeep Chidambar Kulkarni
Source: wkrb13.com

Tourmaline Bio, Inc. (NASDAQ:TRML) Director Buys $17,310.00 in Stock

Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) Director Parvinder Thiara bought 1,000 shares of Tourmaline Bio stock in a transaction dated Friday, November 17th. The stock was purchased at an average price of $17.31 per share, with a total value of $17,310.00. Following the purchase, the director now directly owns 83,782 shares in the […]
New York United States Piper Sandler Parvinder Thiara Securities Exchange Commission Tourmaline Bio Inc

Tourmaline Bio (NASDAQ:TRML) Earns Buy Rating from Analysts at Truist Financial

Truist Financial initiated coverage on shares of Tourmaline Bio (NASDAQ:TRML – Free Report) in a research note issued to investors on Friday morning, MarketBeat reports. The firm issued a buy rating and a $43.00 target price on the stock. TRML has been the topic of several other reports. Piper Sandler assumed coverage on shares of […]
New York United States Piper Sandler Caley Castelein Aaron Kantoff Securities Exchange Commission
Source: wkrb13.com

Truist Financial Begins Coverage on Tourmaline Bio (NASDAQ:TRML)

Analysts at Truist Financial began coverage on shares of Tourmaline Bio (NASDAQ:TRML – Get Free Report) in a report released on Friday, Marketbeat.com reports. The brokerage set a “buy” rating and a $43.00 price target on the stock. Truist Financial’s target price indicates a potential upside of 160.92% from the company’s previous close. TRML has […]
New York United States Aaron Kantoff Sandeep Chidambar Kulkarni Piper Sandler Securities Exchange Commission

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science